| Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature E Charafe-Jauffret, C Ginestier, F Iovino, J Wicinski, N Cervera, P Finetti, ... Cancer research 69 (4), 1302-1313, 2009 | 1380 | 2009 |
| How basal are triple‐negative breast cancers? F Bertucci, P Finetti, N Cervera, B Esterni, F Hermitte, P Viens, ... International journal of Cancer 123 (1), 236-240, 2008 | 669 | 2008 |
| Gene expression profiling of breast cell lines identifies potential new basal markers E Charafe-Jauffret, C Ginestier, F Monville, P Finetti, J Adelaïde, ... Oncogene 25 (15), 2273-2284, 2006 | 667 | 2006 |
| Prognostic and predictive value of PDL1 expression in breast cancer R Sabatier, P Finetti, E Mamessier, J Adelaide, M Chaffanet, HR Ali, ... Oncotarget 6 (7), 5449, 2015 | 536 | 2015 |
| Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters F Bertucci, S Salas, S Eysteries, V Nasser, P Finetti, C Ginestier, ... Oncogene 23 (7), 1377-1391, 2004 | 442 | 2004 |
| Integrated profiling of basal and luminal breast cancers J Adélaïde, P Finetti, I Bekhouche, L Repellini, J Geneix, F Sircoulomb, ... Cancer research 67 (24), 11565-11575, 2007 | 429 | 2007 |
| CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction XW Zhao, EM van Beek, K Schornagel, H Van der Maaden, M Van Houdt, ... Proceedings of the National Academy of Sciences 108 (45), 18342-18347, 2011 | 364 | 2011 |
| Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers F Bertucci, P Finetti, N Cervera, E Charafe-Jauffret, E Mamessier, ... Cancer research 66 (9), 4636-4644, 2006 | 347 | 2006 |
| A refined molecular taxonomy of breast cancer M Guedj, L Marisa, A De Reynies, B Orsetti, R Schiappa, F Bibeau, ... Oncogene 31 (9), 1196-1206, 2012 | 326 | 2012 |
| Gene expression profiling identifies molecular subtypes of inflammatory breast cancer F Bertucci, P Finetti, J Rougemont, E Charafe-Jauffret, N Cervera, ... Cancer research 65 (6), 2170-2178, 2005 | 291 | 2005 |
| Basal breast cancer: a complex and deadly molecular subtype F Bertucci, P Finetti, D Birnbaum Current molecular medicine 12 (1), 96-110, 2012 | 290 | 2012 |
| A gene expression signature identifies two prognostic subgroups of basal breast cancer R Sabatier, P Finetti, N Cervera, E Lambaudie, B Esterni, E Mamessier, ... Breast cancer research and treatment 126, 407-420, 2011 | 274 | 2011 |
| Comprehensive profiling of 8p11-12 amplification in breast cancer V Gelsi-Boyer, B Orsetti, N Cervera, P Finetti, F Sircoulomb, C Rougé, ... Molecular Cancer Research 3 (12), 655-667, 2005 | 272 | 2005 |
| Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome B Chetaille, F Bertucci, P Finetti, B Esterni, A Stamatoullas, JM Picquenot, ... Blood, The Journal of the American Society of Hematology 113 (12), 2765-3775, 2009 | 261 | 2009 |
| Retinoid signaling regulates breast cancer stem cell differentiation C Ginestier, J Wicinski, N Cervera, F Monville, P Finetti, F Bertucci, ... Cell cycle 8 (20), 3297-3302, 2009 | 254 | 2009 |
| ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia V Gelsi‐Boyer, V Trouplin, J Roquain, J Adélaïde, N Carbuccia, B Esterni, ... British journal of haematology 151 (4), 365-375, 2010 | 245 | 2010 |
| Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy F Bertucci, P Finetti, J Rougemont, E Charafe-Jauffret, V Nasser, B Loriod, ... Cancer research 64 (23), 8558-8565, 2004 | 237 | 2004 |
| H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b C Vennin, N Spruyt, F Dahmani, S Julien, F Bertucci, P Finetti, T Chassat, ... Oncotarget 6 (30), 29209, 2015 | 223 | 2015 |
| Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms M Brecqueville, J Rey, F Bertucci, E Coppin, P Finetti, N Carbuccia, ... Genes, Chromosomes and Cancer 51 (8), 743-755, 2012 | 211 | 2012 |
| Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer JL Allensworth, MK Evans, F Bertucci, AJ Aldrich, RA Festa, P Finetti, ... Molecular oncology 9 (6), 1155-1168, 2015 | 209 | 2015 |
